已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events

阿巴塔克普 医学 不利影响 内科学 危险系数 人口 安慰剂 置信区间 美罗华 淋巴瘤 替代医学 环境卫生 病理
作者
Takuto Takahashi,Mahmoud Al‐Kofahi,Mutaz M. Jaber,Brandi Bratrude,Kayla Betz,Yvonne Suessmuth,Alison Yu,Donna Neuberg,Sung Won Choi,Jeffrey Davis,Christine N. Duncan,Roger Giller,Michael Grimley,Andrew C. Harris,David A. Jacobsohn,Nahal Lalefar,Nosha Farhadfar,Michael A. Pulsipher,Shalini Shenoy,Aleksandra Petrović,Kirk R. Schultz,Gregory A. Yanik,Bruce R. Blazar,John Horan,Benjamin Watkins,Amelia Langston,Muna Qayed,Leslie S. Kean
出处
期刊:Blood [Elsevier BV]
卷期号:142 (8): 700-710 被引量:3
标识
DOI:10.1182/blood.2023020035
摘要

Abstract In the ABA2 study, the T-cell costimulation blockade agent, abatacept, was safe and effective in preventing acute graft-versus-host disease (aGVHD) after unrelated-donor hematopoietic cell transplant (HCT), leading to US Food and Drug Administration approval. Here, we performed a determination of abatacept pharmacokinetics (PK), which enabled an examination of how abatacept exposure-response relationships affected clinical outcomes. We performed a population PK analysis of IV abatacept using nonlinear mixed-effect modeling and assessed the association between abatacept exposure and key transplant outcomes. We tested the association between the trough after dose 1 (Ctrough_1) and grade (GR) 2 or 4 aGVHD (GR2-4 aGVHD) through day +100. An optimal Ctrough_1 threshold was identified via recursive partitioning and classification tree analysis. This demonstrated that abatacept PK was characterized by a 2-compartment model with first-order elimination. The ABA2 dosing regimen was based on previous work targeting a steady-state abatacept trough of 10 μg/mL. However, a higher Ctrough_1 (≥39 μg/mL, attained in ∼60% of patients on ABA2) was associated with a favorable GR2-4 aGVHD risk (hazard ratio, 0.35; 95% confidence interval, 0.19-0.65; P < .001), with a Ctrough_1 <39 μg/mL associated with GR2-4 aGVHD risk indistinguishable from placebo (P = .37). Importantly, no significant association was found between Ctrough_1 and key safety indicators, including relapse, and cytomegalovirus or Epstein-Barr virus viremia. These data demonstrate that a higher abatacept Ctrough_1 (≥39 μg/mL) was associated with a favorable GR2-4 aGVHD risk, without any observed exposure-toxicity relationships. This trial was registered at www.clinicaltrials.gov as #NCT01743131.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
感动笑完成签到,获得积分10
2秒前
干净的时光完成签到 ,获得积分10
4秒前
云祱完成签到,获得积分10
4秒前
9秒前
kk完成签到 ,获得积分10
11秒前
香蕉觅云应助dandan采纳,获得10
11秒前
14秒前
14秒前
15秒前
斯文钢笔完成签到 ,获得积分10
16秒前
B站萧亚轩发布了新的文献求助10
16秒前
cayde发布了新的文献求助10
17秒前
17秒前
余南发布了新的文献求助10
17秒前
18秒前
华仔应助虚幻踏歌采纳,获得10
19秒前
20秒前
23秒前
Wei发布了新的文献求助10
23秒前
英俊绿柏应助荷子采纳,获得10
25秒前
26秒前
27秒前
lumi完成签到,获得积分10
28秒前
29秒前
8R60d8应助荔枝采纳,获得10
30秒前
Mayday发布了新的文献求助10
30秒前
俭朴紫寒发布了新的文献求助10
31秒前
32秒前
35秒前
小人物的坚持完成签到 ,获得积分10
36秒前
幸福广山发布了新的文献求助10
37秒前
37秒前
41秒前
qiu发布了新的文献求助10
42秒前
苏苏发布了新的文献求助20
44秒前
47秒前
Jasmine发布了新的文献求助10
47秒前
wanci应助cayde采纳,获得10
47秒前
yf完成签到 ,获得积分10
48秒前
52秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3956896
求助须知:如何正确求助?哪些是违规求助? 3502967
关于积分的说明 11110753
捐赠科研通 3233948
什么是DOI,文献DOI怎么找? 1787671
邀请新用户注册赠送积分活动 870713
科研通“疑难数据库(出版商)”最低求助积分说明 802210